Risk factors associated with late cytomegalovirus reactivation after allogeneic stem cell transplantation for hematological malignancies-Reference-Cited by-同舟云学术

Risk factors associated with late cytomegalovirus reactivation after allogeneic stem cell transplantation for hematological malignancies

Published:2007-05-28 Issue:2 Volume:40 Page:125-136
ISSN:0268-3369
Container-title:Bone Marrow Transplantation
language:en
Short-container-title:Bone Marrow Transplant

Author:

Özdemir E,Saliba R M,Champlin R E,Couriel D R,Giralt S A,de Lima M,Khouri I F,Hosing C,Kornblau S M,Anderlini P,Shpall E J,Qazilbash M H,Molldrem J J,Chemaly R F,Komanduri K V

Publisher

Springer Science and Business Media LLC

Subject

Transplantation,Hematology

Link

http://www.nature.com/articles/1705699.pdf

Reference45 articles.

1. Nichols WG, Boeckh M . Recent advances in the therapy and prevention of CMV infections. J Clin Virol 2000; 16: 25–40.

2. Ljungman P . Immune reconstitution and viral infections after stem cell transplantation. Bone Marrow Transplantation 1998; 21 (Suppl 2): S72–S74.

3. Zaia JA, Sissons JG, Riddell S, Diamond DJ, Wills MR, Carmichael AJ et al. Status of cytomegalovirus prevention and treatment in 2000. Hematology (Am Soc Hematol Educ Program) 2000, 339–355.

4. Kollman C, Howe CW, Anasetti C, Antin JH, Davies SM, Filipovich AH et al. Donor characteristics as risk factors in recipients after transplantation of bone marrow from unrelated donors: the effect of donor age. Blood 2001; 98: 2043–2051.

5. Craddock C, Szydlo RM, Dazzi F, Olavarria E, Cwynarski K, Yong A et al. Cytomegalovirus seropositivity adversely influences outcome after T-depleted unrelated donor transplant in patients with chronic myeloid leukaemia: the case for tailored graft-versus-host disease prophylaxis. Br J Haematol 2001; 112: 228–236.

Cited by 117 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Late cytomegalovirus disease after hematopoietic cell transplantation: significance of novel transplantation techniques;Blood Advances;2024-07-11

2. Ten-year epidemiology and risk factors of cytomegalovirus infection in hematopoietic stem cell transplantation patients in Taiwan;Journal of Microbiology, Immunology and Infection;2024-06

3. Surveillance over cytomegalovirus (CMV) reactivation following hematopoietic stem cell transplantation: a single-center experience;Biotechnology & Biotechnological Equipment;2024-03-18

4. Real-Life Data on the Efficacy and Safety of Letermovir for Primary Prophylaxis of Cytomegalovirus in Allogeneic Hematopoietic Stem Cell Recipients: A Single-Center Analysis;Turkish Journal of Hematology;2024-03-04

5. Extended duration letermovir in allogeneic hematopoietic stem cell transplant;Transplant Immunology;2023-12